These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 11435885
1. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. J Urol; 2001 Jul; 166(1):275-80. PubMed ID: 11435885 [Abstract] [Full Text] [Related]
2. Enalapril prevents tubulointerstitial lesions by hyperoxaluria. Toblli JE, Stella I, de Cavanagh E, Angerosa M, Inserra F, Ferder L. Hypertension; 1999 Jan; 33(1 Pt 2):225-31. PubMed ID: 9931109 [Abstract] [Full Text] [Related]
3. Enalapril prevents fatty liver in nephrotic rats. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. J Nephrol; 2002 Jan; 15(4):358-67. PubMed ID: 12243364 [Abstract] [Full Text] [Related]
4. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. Toblli JE, Ferder L, Stella I, De Cavanaugh EM, Angerosa M, Inserra F. J Urol; 2002 Oct; 168(4 Pt 1):1550-5. PubMed ID: 12352456 [Abstract] [Full Text] [Related]
5. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage]. Toblli JE, Angerosa M, Stella I, Ferder L, Inserra F. Medicina (B Aires); 2003 Oct; 63(2):97-104. PubMed ID: 12793076 [Abstract] [Full Text] [Related]
6. [Dilingdan Decoction prevents renal interstitial fibrosis in a rat model of unilateral ureteral obstruction]. Huan HD, Zhang JH, Zheng SR, Meng WW, Zhang JL. Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):493-7. PubMed ID: 18471414 [Abstract] [Full Text] [Related]
7. Potassium citrate administration ameliorates tubulointerstitial lesions in rats with uric acid nephropathy. Toblli JE, DeRosa G, Lago N, Angerosa M, Nyberg C, Pagano P. Clin Nephrol; 2001 Jan; 55(1):59-68. PubMed ID: 11200869 [Abstract] [Full Text] [Related]
8. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, Slatopolsky E. J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326 [Abstract] [Full Text] [Related]
9. Role of myofibroblasts, macrophages, transforming growth factor-beta endothelin, angiotensin-II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. Geleilete TJ, Melo GC, Costa RS, Volpini RA, Soares TJ, Coimbra TM. J Nephrol; 2002 Jun; 15(6):633-42. PubMed ID: 12495276 [Abstract] [Full Text] [Related]
10. Atorvastatin inhibits renal crystal retention in a rat stone forming model. Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A. J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815 [Abstract] [Full Text] [Related]
12. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Song J, Meng L, Li S, Qu L, Li X. Vascul Pharmacol; 2009 Aug; 50(5-6):185-93. PubMed ID: 19563735 [Abstract] [Full Text] [Related]
13. Effects of amlodipine on tubulointerstitial lesions in normotensive hyperoxaluric rats. Toblli JE, Ferder L, Angerosa M, Inserra F. Hypertension; 1999 Oct; 34(4 Pt 2):854-8. PubMed ID: 10523373 [Abstract] [Full Text] [Related]
14. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure. Okada K, Okawa E, Shibahara H, Maruyama T, Maruyama N, Matsumoto K, Takahashi S. Kidney Blood Press Res; 2004 Oct; 27(4):218-25. PubMed ID: 15273424 [Abstract] [Full Text] [Related]
15. Renal haemodynamics and function in weanling rats treated with enalapril from birth. Guron G. Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949 [Abstract] [Full Text] [Related]
16. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals. Huang HS, Ma MC, Chen J, Chen CF. Neurourol Urodyn; 2003 Oct; 22(2):176-82. PubMed ID: 12579636 [Abstract] [Full Text] [Related]
17. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction? Srisawat N, Manotham K, Eiam-Ong S, Katavetin P, Praditpornsilpa K, Eiam-Ong S. Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748 [Abstract] [Full Text] [Related]
18. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Volpini RA, da Silva CG, Costa RS, Coimbra TM. Diabetes Metab Res Rev; 2003 Oct; 19(1):43-51. PubMed ID: 12592643 [Abstract] [Full Text] [Related]
19. N-Acetylcysteine ameliorates lithium-induced renal failure in rats. Efrati S, Averbukh M, Berman S, Feldman L, Dishy V, Kachko L, Weissgarten J, Golik A, Averbukh Z. Nephrol Dial Transplant; 2005 Jan; 20(1):65-70. PubMed ID: 15546888 [Abstract] [Full Text] [Related]
20. Is enalapril adequate for the prevention of renal tissue damage caused by unilateral ureteral obstruction and/or hyperoxaluria? Turan T, van Harten JG, de Water R, Tuncay OL, Kok DJ. Urol Res; 2003 Jul; 31(3):212-7. PubMed ID: 12719949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]